Merdury Biopharmaceutical Corporation (6932)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
6. 16
+0.05
+0.8183%
NT$
- Market Cap
- P/E Ratio
88% Div Yield
481,020 Volume
- Eps
NT$ 6.11
Previous Close Want to track 6932 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Merdury Biopharmaceutical Corporation (6932) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.9B
Trailing P/E (ttm) -59.46
Forward P/E -
PEG ratio -1.84
Price/Sales (ttm) -
Price/Book (mrq) 15.93
Enterprise Value/Revenue -
Enterprise Value/EBITDA -70.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 658.37K
Average volume (90 days) 484.48K
Price summary
52-Week low 4.71
52-Week high 12.2
Beta -
50-Day moving average 5.87
200-Day moving average 6.54
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.2%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.3
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 7.76%
Book value per share (mrq) 0.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
